Kim Jeong-a, Montagnani Monica, Koh Kwang Kon, Quon Michael J
Diabetes Unit, National Center for Complementary and Alternative Medicine, National Institutes of Health, Bethesda, MD 20892-1632, USA.
Circulation. 2006 Apr 18;113(15):1888-904. doi: 10.1161/CIRCULATIONAHA.105.563213.
Endothelial dysfunction contributes to cardiovascular diseases, including hypertension, atherosclerosis, and coronary artery disease, which are also characterized by insulin resistance. Insulin resistance is a hallmark of metabolic disorders, including type 2 diabetes mellitus and obesity, which are also characterized by endothelial dysfunction. Metabolic actions of insulin to promote glucose disposal are augmented by vascular actions of insulin in endothelium to stimulate production of the vasodilator nitric oxide (NO). Indeed, NO-dependent increases in blood flow to skeletal muscle account for 25% to 40% of the increase in glucose uptake in response to insulin stimulation. Phosphatidylinositol 3-kinase-dependent insulin-signaling pathways in endothelium related to production of NO share striking similarities with metabolic pathways in skeletal muscle that promote glucose uptake. Other distinct nonmetabolic branches of insulin-signaling pathways regulate secretion of the vasoconstrictor endothelin-1 in endothelium. Metabolic insulin resistance is characterized by pathway-specific impairment in phosphatidylinositol 3-kinase-dependent signaling, which in endothelium may cause imbalance between production of NO and secretion of endothelin-1, leading to decreased blood flow, which worsens insulin resistance. Therapeutic interventions in animal models and human studies have demonstrated that improving endothelial function ameliorates insulin resistance, whereas improving insulin sensitivity ameliorates endothelial dysfunction. Taken together, cellular, physiological, clinical, and epidemiological studies strongly support a reciprocal relationship between endothelial dysfunction and insulin resistance that helps to link cardiovascular and metabolic diseases. In the present review, we discuss pathophysiological mechanisms, including inflammatory processes, that couple endothelial dysfunction with insulin resistance and emphasize important therapeutic implications.
内皮功能障碍会导致心血管疾病,包括高血压、动脉粥样硬化和冠状动脉疾病,这些疾病也都具有胰岛素抵抗的特征。胰岛素抵抗是代谢紊乱的标志,包括2型糖尿病和肥胖症,这些疾病同样具有内皮功能障碍的特征。胰岛素促进葡萄糖代谢的作用会因胰岛素在内皮中的血管作用而增强,从而刺激血管舒张剂一氧化氮(NO)的产生。实际上,依赖NO的骨骼肌血流增加占胰岛素刺激后葡萄糖摄取增加量的25%至40%。内皮中与NO产生相关的磷脂酰肌醇3激酶依赖性胰岛素信号通路与促进葡萄糖摄取的骨骼肌代谢通路有显著相似之处。胰岛素信号通路的其他不同非代谢分支调节内皮中血管收缩剂内皮素-1的分泌。代谢性胰岛素抵抗的特征是磷脂酰肌醇3激酶依赖性信号通路出现特定途径的损伤,这在内皮中可能导致NO产生与内皮素-1分泌之间的失衡,进而导致血流减少,使胰岛素抵抗恶化。在动物模型和人体研究中的治疗干预表明,改善内皮功能可改善胰岛素抵抗,而改善胰岛素敏感性可改善内皮功能障碍。综合来看,细胞、生理、临床和流行病学研究有力地支持了内皮功能障碍与胰岛素抵抗之间的相互关系,这种关系有助于将心血管疾病和代谢性疾病联系起来。在本综述中,我们讨论了将内皮功能障碍与胰岛素抵抗联系起来的病理生理机制,包括炎症过程,并强调了重要的治疗意义。